Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2934468 | International Journal of Cardiology | 2008 | 5 Pages |
Abstract
22q11.2 deletion in non-syndromic TOF patients is present in approximately 6% of patients. We suggest a tendency towards a higher prevalence of pulmonary atresia in non-syndromic TOF patients with 22q11 microdeletion. Molecular genetic screening of non-syndromic TOF patient may be important for the correct care of these patients and a more specific genetic diagnostic and counseling.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
L. Gioli-Pereira, A.C. Pereira, D. Bergara, S. Mesquita, A.A. Lopes, J.E. Krieger,